FT : Turkey raises interest rates for fifth time in as many months

Turkey raises interest rates for fifth time in as many months
Central bank’s efforts to bring down inflation could be complicated by any escalation of Israel-Hamas conflict

Turkey has raised interest rates for the fifth time since June as the country steps up its battle against inflation and the threat of escalating conflict in the Middle East poses a fresh challenge to policymakers.

The central bank on Thursday increased the benchmark one-week repo rate by 5 percentage points to 35 per cent, matching the expectation of economists in a Reuters poll.

The big rate rise is the latest sign of how Turkey has sharply pivoted its economic policy since President Recep Tayyip Erdoğan was re-elected in May. Central bank chief Hafize Gaye Erkan has vowed since her appointment in June to tighten monetary policy as much as is necessary to cool inflation, which is running at more than 60 per cent. 

“Monetary tightening will be further strengthened as much as needed in a timely and gradual manner until a significant improvement in inflation outlook is achieved,” the central bank said, as it warned that “geopolitical developments pose risks to the inflation outlook” if they led to higher oil prices.

The price of international crude benchmark Brent has jumped nearly 20 per cent to $88 a barrel since the start of June. Production and export cuts by Saudi Arabia and Russia have partly driven the rally. But analysts also fear that any broadening of the Israel-Hamas war into a wider regional conflict will send prices even higher. 

Turkey imports the bulk of its energy and, in addition to boosting inflation, higher oil prices will make it more difficult for the government to achieve its goal of narrowing the country’s massive current account deficit. 


The central bank’s policy tightening and its recent communications have helped to rebuild its credibility and generate confidence that it is taking a more serious stance against inflation,” said Liam Peach, senior emerging markets economist analyst at Capital Economics.

Erkan’s central bank has more than quadrupled the one-week repo rate since June in an attempt to rein in inflation, which has been fuelled both by overheating domestic demand and elevated energy prices.

The higher-rate policy marks a stark contrast to Erdoğan’s long-held insistence that borrowing costs should be kept at low levels despite a prolonged period of high inflation.

Erdoğan in September publicly embraced tight monetary policy, something that has helped to ease scepticism that the Turkish president will change course ahead of next year’s local elections in which his Justice and Development party will attempt to take back control of the country’s biggest city, Istanbul. 

A central bank poll before Thursday’s rate decision showed Turkish investors and business leaders expected the one-week repo rate to be 39 per cent a year from now, highlighting how the local business community is braced for a long period of high borrowing costs. 

Higher rates are part of a broader economic overhaul that is being led by finance minister Mehmet Şimşek, who was appointed in June. The government has boosted taxes, taken a series of actions to slow consumer and commercial lending growth and allowed the lira to fluctuate more freely after curtailing a costly programme to prop it up. 

Foreign investors, who fled Turkey after years of unorthodox economic policies, have broadly taken an upbeat view on the new programme even if they remain sceptical about how much leeway policymakers will have ahead of next year’s municipal elections. 

Investors are also paying keen attention to Erdoğan’s response to the Israel-Hamas conflict. The Turkish president has stepped up his rhetoric against the Jewish state and its western allies in recent days. Turkish stocks fell sharply on Wednesday after he said Hamas, whose militants killed at least 1,400 people in its October 7 attack on Israel, was not a terrorist organisation but rather a “group for liberation”.

Helping to counterbalance those concerns was Erdoğan’s decision this week to send Sweden’s request for accession to Nato to Turkey’s parliament. The US and Europe have both been pushing Ankara to ratify Sweden’s accession into the military alliance.

>>> US Research Calls

Research Calls
  • Upgrades:
    • Adobe (ADBE) upgraded to Buy from Neutral and added to Best-of-Breed Bison list at DA Davidson; tgt raised to $640
    • Akamai Tech (AKAM) upgraded to Neutral from Sell at Guggenheim
    • Canadian Pacific (CP) upgraded to Outperform from Mkt Perform at Raymond James
    • Centessa Pharmaceuticals (CNTA) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $8
    • Installed Building Products (IBP) upgraded to Buy from Hold at The Benchmark Company; tgt $150
    • Live Nation (LYV) upgraded to Outperform from In-line at Evercore ISI; tgt $100
    • Microsoft (MSFT) upgraded to Buy from Hold at HSBC Securities; tgt raised to $413
    • Okta (OKTA) upgraded to Buy from Outperform at Daiwa Securities; tgt $87
    • Snap (SNAP) upgraded to Hold from Sell at China Renaissance; tgt $9
    • Sociedad Quimica y Minera (SQM) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt $84
    • UMB Financial Corporation (UMBF) upgraded to Strong Buy from Outperform at Raymond James; tgt lowered to $80
    • UMB Financial Corporation (UMBF) upgraded to Buy from Neutral at Janney; tgt $73
  • Downgrades:
    • Arcutis Biotherapeutics (ARQT) downgraded to Neutral from Buy at Mizuho; tgt lowered to $4
    • Atlantica Yield (AY) downgraded to Mkt Perform from Outperform at Raymond James; tgt lowered to $25
    • Barclays PLC (BCS) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $7.31
    • Bath & Body Works (BBWI) downgraded to Hold from Buy at Jefferies; tgt lowered to $30
    • BOK Financial (BOKF) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $70
    • F5 Networks (FFIV) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $160
    • Fortive (FTV) downgraded to Neutral from Buy at BofA Securities; tgt $70
    • MaxLinear (MXL) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $18
    • Papa John's (PZZA) downgraded to Neutral from Outperform at Wedbush; tgt $95
    • Thermo Fisher (TMO) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Valmont (VMI) downgraded to Neutral from Buy at Northcoast
  • Others:
    • 4D Molecular Therapeutics (FDMT) initiated with an Outperform at RBC Capital Mkts; tgt $25
    • Alcoa (AA) initiated with a Buy at DBS Bank; tgt $41
    • EverQuote (EVER) resumed with a Mkt Perform at Raymond James
    • Paycom Software (PAYC) initiated with a Buy at BofA Securities; tgt $330
    • Paylocity (PCTY) initiated with a Neutral at BofA Securities; tgt $210
    • Procore Technologies (PCOR) initiated with an Outperform at BMO Capital Markets; tgt $80
    • Rocket Lab USA (RKLB) initiated with an Overweight at Cantor Fitzgerald; tgt $6

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • PI +18%, OPRA +10%, NOVA +9.6%, NAAS +9.5%, FLEX +8.9% (also to spin off remaining interest in NXT), HZO +8.2%, BFH +7.7%, EGBN +7.5%, CNMD +6.8%, FIBK +5.8%, NXT +5.2% (also announces plan to separate from FLEX), CCS +5.2%, CMPR +5.2%, SUI +4.9%, AMBP +4.6%, AGI +4.4%, WFG +4.3%, FLS +4%, NOW +3.9% (also announces strategic partnership to power GCCs), MBLY +3.7%, RITM +3.7%, OSK +3.6%, NTGR +3.5%, ORLY +3.3%, HSY +3.1%, MEOH +3%, CASH +3%, LXFR +2.8% (also initiates strategic review), PEGA +2.6%, TAL +2.6%, STM +2.5%, NVCR +2.5%, ARCH +2.2%, CHDN +2%, BHE +2%, KRC +2%, ESI +2%, PLXS +2%, STC +2%, TIGO +1.8%, TXT +1.8%, FTI +1.5%, AEM +1.4%, CVBF +1.3%, MAS +1.2%, IBM +1.1%, EXLS +1.1%, MDC +1.1%, CARR +1.1%, WEX +1.1%, CMS +1%
Other news:
  • EDR +23% (to evaluate strategic alternatives)
  • SELB +4.3% (files $200 mln mixed shelf securities offering)
  • F +2.5% (reaches tentative agreement on record contract with Ford Motor)
  • BIIB +2.4% (Eisai presents new LEQEMBI interim study results)
  • FLR +2% (awarded contract for battery production facility)
  • RKLB +1.7% (receives FAA authorization to resume launches from Launch Complex 1)
  • AMSF +1.6% (declares special dividend of $3.50/sh)
  • CHH +1.5% (CHH calls on WH to engage in good faith M&A discussions)
Analyst comments:
  • CNTA +5% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
  • AKAM +0.5% (upgraded to Neutral from Sell at Guggenheim)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • ALGN -23.5%, MXL -22.1%, SLP -13.1%, MAT -11.1%, HAS -11%, VKTX -10.7%, EW -7.3%, BC -6.9%, MYRG -6.6%, WHR -6.1%, UCTT -5.1% (also acquires HIS Innovations Group), TSCO -5.1%, TPH -5%, SHYF -5%, BMY -4.9%, LUV -4.7%, SBSI -4.4%, AGR -4.2%, WST -4.2%, CYH -4.1%, FTAI -4%, URI -4%, OII -3.9%, ALSN -3.8%, KALU -3.8%, META -3.8%, CLS -3.5%, ENSG -3.3%, VMI -3.2%, UL -3.2%, TAK -3.1%, BG -3.1%, IEX -3% (also names new CFO), UPS -3%, LEA -2.8%, QS -2.7%, INVH -2.7%, EIG -2.6%, VLTO -2.5%, HTZ -2.5%, VMC -2.4%, GSHD -2.3%, OSTK -2.3%, SAVE -2.3%, KVUE -2.2%, IP -2.1%, LKQ -2%, WCN -1.8% (also increases dividend), CMCSA -1.8%, LSTR -1.7%, EG -1.7%, WPP -1.6%, ATR -1.4%, LC -1.4%, LH -1.4%, TER -1.1%, TER -1.1%, ROL -1%, FCFS -1%, ULCC -1%
Other news:
  • ITRI -1.8% (unveils I.E.E. settlements)
  • STLA -1.7% (to become a strategic shareholder of Leapmotor with €1.5 billion investment)
  • CBUS -1.4% (files $200 mln mixed shelf securities offering)
  • LIAN -1.2% (announces presentation of data from Phase 2a study of Infigratinib)
Analyst comments:
  • ARQT -3.8% (downgraded to Neutral from Buy at Mizuho)
  • FTV -2.5% (downgraded to Neutral from Buy at BofA Securities)
  • BCS -2.3% (downgraded to Underperform from Neutral at BofA Securities)
  • BOKF -2.3% (downgraded to Equal Weight from Overweight at Wells Fargo)
  • BBWI -2.2% (downgraded to Hold from Buy at Jefferies)
  • TMO -1.5% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)

>>> Oshkosh reports Q3 EPS of $3.04 vs. $2.20 FactSet consensus; revs +21% yr/yr

Oshkosh reports Q3 EPS of $3.04 vs. $2.20 FactSet consensus; revs +21% yr/yr to $2.51 bln vs. $2.47 bln FactSet consensus (86.86)
  • Co raises to FY23 EPS of $9.50 from $8.00 vs. $8.16 FactSet consensus; revs $9.65 bln from $9.5 bln vs. $9.53 bln FactSet consensus
  • Access - Access segment sales for the third quarter of fiscal 2023 increased 27.0 percent to $1.32 billion as a result of improved sales volume, higher pricing in response to higher input costs and the inclusion of sales of $19.0 million related to the Hinowa acquisition.
  • Access segment operating income in the third quarter of fiscal 2023 increased 93.5 percent to $229.9 million, or 17.4 percent of sales, compared to $118.8 million, or 11.4 percent of sales, in the third quarter of fiscal 2022. The increase was primarily due to higher sales volume, improved price/cost dynamics and improved product mix, offset in part by higher incentive compensation costs and increased operating expenses to support the higher sales levels.

>>> Mobileye Global beats by $0.05, reports revs in-line; lowers top end of FY23

Mobileye Global beats by $0.05, reports revs in-line; lowers top end of FY23 guidance (33.96)
  • Reports Q3 (Sep) earnings of $0.22 per share, excluding non-recurring items, $0.05 better than the FactSet Consensus of $0.17; revenues rose 17.8% year/year to $530 mln vs the $528.63 mln FactSet Consensus.
  • Co lowers top end of FY23 revenue guidance to $2.065-2.09 bln from $2.065-2.114 bln prior guidance (no comparable estimates).
  • "We are very pleased with Q3 results, as operating leverage on strong revenue growth has led to significant increases in operating income," said Mobileye President and CEO Prof. Amnon Shashua. "On the product side, very positive consumer and media feedback to the August roll-out of the SuperVision navigate on pilot software to Zeekr vehicles was a key proof-point of the competitive advantages of our advanced products. This in part led to (i) conversions with Polestar and FAW during the quarter, (ii) continued progress with the balance of the 9 core OEM prospects we noted on our last earnings call, and (iii) new interest from an additional wave of global automakers. Since the end of Q3, the tragic events in Israel have affected us all, but strong business continuity planning, lessons learned during COVID-19 disruptions, and the diligence of our remarkable team has enabled us to limit disruption and continue to execute our business priorities."

>>> Lazard misses by $0.06, misses on revs (27.55)

Lazard misses by $0.06, misses on revs (27.55)
  • Reports Q3 (Sep) earnings of $0.10 per share, $0.06 worse than the FactSet Consensus of $0.16; revenues fell 26.8% year/year to $532 mln vs the $572.54 mln FactSet Consensus.
  • Financial Advisory operating revenue was $261 million, 42% lower than the third quarter of 2022.
  • Asset Management operating revenue was $262 million, flat compared to the third quarter of 2022.

>>> TechnipFMC beats by $0.02, beats on revs (19.93)

TechnipFMC beats by $0.02, beats on revs (19.93)
  • Reports Q3 (Sep) earnings of $0.21 per share, excluding non-recurring items, $0.02 better than the FactSet Consensus of $0.19; revenues rose 18.7% year/year to $2.06 bln vs the $1.98 bln FactSet Consensus.
  • Co sees Subsea Revenue in a range of $5.9 - 6.3 billion

>>> Manchester United reports Q4 results, beats on revs; guides FY24 revs below

Manchester United reports Q4 results, beats on revs; guides FY24 revs below consensus
  • Reports Q4 (Jun) loss of GBP0.06 per share, excluding non-recurring items, GBP0.02 worse than the single analyst estimate of (GBP0.04); revenues rose 41.2% year/year to GBP167.3 mln vs the GBP154 mln single analyst estimate.
  • Co issues downside guidance for FY24, sees FY24 revs of GBP650-680 mln vs. GBP709.33 mln FactSet Consensus